Publications et communications de Olivier Peulen

Reynders, C., Bruyère, D., RONCARATI, P., Geuzaine, R., KOOPMANSCH, B., Gofflot, S., Monnien, F., Craciun, L., Piazzon, N., Hendrick, E., Poulain, F., Lerho, T., Miceli, S., Pilard, C., Ancion, M., Luyckx, M., Renard, M., Lambert, F., Gheit, T., ... Herfs, M. (December 2025). Human Papillomavirus Infection Is a Favorable Prognostic Factor for Patients With Stages I to IVA Esophageal Squamous Cell Carcinoma but not Adenocarcinoma. Modern Pathology, 38 (12), 100853. doi:10.1016/j.modpat.2025.100853

Gullo, C.* , Laverdeur, E.* , Dancre, M., Peiffer, R., Boumahd, Y., Agirman, F., Maloujahmoum, N., Désiront, L., Thiry, M., Rademaker, G., Bellahcene, A., & Peulen, O. (28 November 2025). Focal adhesion assembly and cell migration require myoferlin in PDAC cell lines. Scientific Reports, 15 (1). doi:10.1038/s41598-025-27134-2

Peiffer, R., Laverdeur, E., Gaigneaux, A., Boumahd, Y., Gullo, C., Rademaker, G., Crake, R., Lavergne, A., Maloujahmoum, N., Agirman, F., Herfs, M., Masamune, A., Letellier, E., Bellahcene, A., & Peulen, O. (2025). Targeting myoferlin in ER/Golgi vesicle trafficking reprograms pancreatic cancer-associated fibroblasts. EMBO Journal. doi:10.1038/s44318-025-00570-6

Pilard, C., RONCARATI, P., Ancion, M., Luyckx, M., Renard, M., Reynders, C., Lerho, T., Poulain, F., Bruyère, D., LEBEAU, A., Hendrick, E., Crake, R., Peiffer, R., Nokin, M.-J., Peulen, O., Delvenne, P., Hubert, P.* , & Herfs, M.*. (13 March 2025). RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells. Journal for ImmunoTherapy of Cancer, 13 (3), 010753. doi:10.1136/jitc-2024-010753

Chen, X., Tsvetkov, A. S., Shen, H.-M., Isidoro, C., Ktistakis, N. T., Linkermann, A., Koopman, W. J. H., Simon, H.-U., Galluzzi, L., Luo, S., Xu, D., Gu, W., Peulen, O., Cai, Q., Rubinsztein, D. C., Chi, J.-T., Zhang, D. D., Li, C., Toyokuni, S., ... Tang, D. (2024). International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis. Autophagy. doi:10.1080/15548627.2024.2319901

Anania, S., Farnir, M., Peiffer, R., Boumahd, Y., Thiry, M., Agirman, F., Maloujahmoum, N., Bellahcene, A., & Peulen, O. (17 February 2024). Identification of myoferlin as a mitochondria-associated membranes component required for calcium signaling in PDAC cell lines. Cell Communication and Signaling, 22 (1), 133. doi:10.1186/s12964-024-01514-z

Iovino, M., Colonval, M., Wilkin, C., L'Homme, L., Lassence, C., Campas, M., Peulen, O., De Tullio, P., Piette, J., & Legrand, S. (2023). Novel XBP1s-independent function of IRE1 RNase in HIF-1α-mediated glycolysis upregulation in human macrophages upon stimulation with LPS or saturated fatty acid. Frontiers in Immunology. doi:10.3389/fimmu.2023.1204126

Cremer, J., Brohée, L., Dupont, L., Lefevre, C., Peiffer, R., Saarinen, A. M., Peulen, O., Bindels, L., Liu, J., Colige, A., & Deroanne, C. (11 July 2023). Acidosis-induced regulation of adipocyte G0S2 promotes crosstalk between adipocytes and breast cancer cells as well as tumor progression. Cancer Letters, 569, 216306. doi:10.1016/j.canlet.2023.216306

Crake, R., Kiweler, N., Thiry, M., Peulen, O., Blomme, A., Meiser, J., Ambrogio, C., Santamaria, D., Cataldo, D., & Nokin, M.-J. (June 2023). Targeting metabolic adaptations in drug tolerant BRAFV600E mutant NSCLC [Poster presentation]. EACR 2023, Torino, Italy.

Crake, R., Gasmi, I., Dehaye, J., Lardinois, F., Peiffer, R., Maloujahmoum, N., Agirman, F., KOOPMANSCH, B., D’Haene, N., Azurmendi Senar, O., Arsenijevic, T., Lambert, F., Peulen, O., Van Laethem, J.-L., & Bellahcene, A. (17 May 2023). Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response. Cells, 12 (10), 1414. doi:10.3390/cells12101414

Dube, G., Tiamiou, A., Bizet, M., Boumahd, Y., Gasmi, I., Crake, R., Bellier, J., Nokin, M.-J., Calonne, E., Deplus, R., Wissocq, T., Peulen, O., Castronovo, V., Fuks, F., & Bellahcene, A. (31 March 2023). Methylglyoxal: a novel upstream regulator of DNA methylation. Journal of Experimental and Clinical Cancer Research, 42 (1), 78. doi:10.1186/s13046-023-02637-w

Rademaker, G., Costanza, B., Bellier, J., Herfs, M., Peiffer, R., Agirman, F., Maloujahmoum, N., Habraken, Y., Delvenne, P., Bellahcene, A., Castronovo, V., & Peulen, O. (02 March 2023). Correction: Human colon cancer cells highly express myoferlin to maintain a fit mitochondrial network and escape p53-driven apoptosis. Oncogenesis, 12 (1), 11. doi:10.1038/s41389-023-00455-5

Bruyere, D., RONCARATI, P., Lebeau, A., Lerho, T., Poulain, F., Hendrick, E., Pilard, C., Reynders, C., Ancion, M., Luyckx, M., Renard, M., Jacob, Y., Twizere, J.-C., Peiffer, R., Peulen, O., Delvenne, P., Hubert, P., McBride, A., Gillet, N., ... Herfs, M. (2023). Human papillomavirus E6/E7 oncoproteins promote radiotherapy-mediated tumor suppression by globally hijacking host DNA damage repair. Theranostics, 13 (3), 1130 - 1149. doi:10.7150/thno.78091

Peiffer, R., Boumahd, Y., Gullo, C., Crake, R., Letellier, E., Bellahcene, A., & Peulen, O. (22 December 2022). Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer. Cancers, 15 (1), 61. doi:10.3390/cancers15010061

Lemaitre, F.* , Chakrama, F.* , O'Grady, T., Peulen, O., Rademaker, G., Deward, A., Chabot, B., Piette, J., Colige, A., Lambert, C., Dequiedt, F.* , & Habraken, Y.*. (09 December 2022). The transcription factor c-Jun inhibits RBM39 to reprogram pre-mRNA splicing during genotoxic stress. Nucleic Acids Research, 50 (22), 12768 - 12789. doi:10.1093/nar/gkac1130

Chen, D., Nemazanyy, I., Peulen, O., Shostak, K., Xu, X., Tang, S. C., Wathieu, C., Turchetto, S., Tielens, S., Nguyen, L., Close, P., Desmet, C., Klein, S., Florin, A., Büttner, R., Petrellis, G., Dewals, B. G., & Chariot, A. (2022). Elp3-mediated codon-dependent translation promotes mTORC2 activation and regulates macrophage polarization. EMBO Journal, 109353. doi:10.15252/embj.2021109353

Rademaker, G.* , Boumahd, Y.* , Peiffer, R., Anania, S., Wissocq, T., Liégeois, M., Luis, G., Sounni, N. E., Agirman, F., Maloujahmoum, N., De Tullio, P., Thiry, M., Bellahcene, A., Castronovo, V., & Peulen, O. (July 2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Redox Biology, 53, 102324. doi:10.1016/j.redox.2022.102324

Boumahd, Y., Rademaker, G., Peiffer, R., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., & Peulen, O. (22 June 2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells [Poster presentation]. EACR 2022.

Rademaker, G., Costanza, B., Pyr Dit Ruys, S., Peiffer, R., Agirman, F., Maloujahmoum, N., Vertommen, D., Turtoi, A., Bellahcene, A., Castronovo, V.* , & Peulen, O.*. (2022). Paladin, overexpressed in colon cancer, is required for actin polymerisation and liver metastasis dissemination. Oncogenesis, 11, 42. doi:10.1038/s41389-022-00416-4

Crake, R., Agirman, F., Arsenijevic, T., Maloujahmoum, N., Peulen, O., Van Laethem, J.-L., & Bellahcene, A. (14 October 2021). Improving pancreatic cancer response to gemcitabine by overcoming methylglyoxal driven suppression of AMPK [Poster presentation]. GIGA-Cancer Day, Liege, Belgium.

Dumont, E., De Bleye, C., Rademaker, G., Coic, L., Horne, J., Sacre, P.-Y., Peulen, O., Hubert, P., & Ziemons, E. (01 March 2021). Development of a prototype device for near real-time surface-enhanced Raman scattering monitoring of biological samples. Talanta, 224, 121866. doi:10.1016/j.talanta.2020.121866

Hubert, P., RONCARATI, P., Demoulin, S., Pilard, C., Ancion, M., Reynders, C., Lerho, T., Bruyère, D., Lebeau, A., Radermecker, C., Meunier, M., Nokin, M.-J., Hendrick, E., Peulen, O., Delvenne, P., & Herfs, M. (2021). Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy. Journal for ImmunoTherapy of Cancer, 9 ((3)), 001966. doi:10.1136/jitc-2020-001966

Anania, S., Peiffer, R., Rademaker, G., Hego, A., Thiry, M., Deldicque, L., Francaux, M., Maloujahmoum, N., Agirman, F., Bellahcene, A., Castronovo, V., & Peulen, O. (21 June 2020). Myoferlin is a yet unknown interactor of the mitochondrial dynamics’ machinery in pancreas cancer cells. Cancers, 12 (6), 1643. doi:10.3390/cancers12061643

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., KOOPMANSCH, B., MacKay, G. M., Chiavarina, B., Costanza, B., Rademaker, G., Durieux, F., Agirman, F., Maloujahmoum, N., Cusumano, P. G., LOVINFOSSE, P., Leung, H. Y., LAMBERT, F., Bours, V., ... Bellahcene, A. (04 February 2020). Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab. Cell Reports, 30 (5), 1400-1416.e6. doi:10.1016/j.celrep.2020.01.012

Anania, S., Rademaker, G., Peiffer, R., Hego, A., Deldicque, L., Maloujahmoum, N., Agirman, F., Bellahcene, A., Castronovo, V., & Peulen, O. (February 2020). Role of myoferlin in mitochondrial dynamics and metabolic fitness of pancreas cancer [Poster presentation]. BACR Annual Meeting 2020 - Cancer metastases: from bedside to bench, Brussels, Belgium.

Anania, S., Rademaker, G., Bellahcene, A., Castronovo, V., & Peulen, O. (December 2019). Role of myoferlin in mitochondrial dynamics and metabolic fitness of Pancreatic Ductal Adenocarcinoma [Poster presentation]. Second CIRM Scientific Day, Liège, Belgium.

Rademaker, G., Costanza, B., Bellier, J., Herfs, M., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (26 November 2019). Myoferlin depletion induces DNA damage response and p53- dependent cell cycle arrest and apoptosis in colon cancer [Poster presentation]. Metabolism in Cancer and Stromal Cells (2nd edition), Leuven, Belgium.

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (23 October 2019). Myoferlin Contributes to the Metastatic Phenotype of Pancreatic Cancer Cells by Enhancing Their Migratory Capacity Through the Control of Oxidative Phosphorylation [Poster presentation]. Pancreatic Cancer Symposium, Toulouse, France.

Anania, S., Rademaker, G., Wissocq, T., Bellahcene, A., Castronovo, V., & Peulen, O. (October 2019). Role of myoferlin in mitochondrial dynamics and metabolic fitness of PDAC [Poster presentation]. PANCREATIC CANCER SYMPOSIUM, Toulouse, France.

Costanza, B., Rademaker, G., Turtoi, A., Bellahcene, A., Castronovo, V., & Peulen, O. (October 2019). TGFBI, an ECM interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration [Poster presentation]. Pancreatic Cancer Symposium 2019, Toulouse, France.

Anania, S., Rademaker, G., Wissocq, T., Bellahcene, A., Castronovo, V., & Peulen, O. (06 September 2019). Role of myoferlin in mitochondrial dynamics and metabolic fitness of pancreas cancer [Poster presentation]. EDT Cancerology 2019, Bruxelles, Belgium.

Peulen, O., Rademaker, G., Anania, S., Turtoi, A., Bellahcene, A., & Castronovo, V. (August 2019). Ferlin overview: from membrane to cancer biology. Cells, 8, 954. doi:10.3390/cells8090954

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (13 June 2019). Myoferlin Contributes to the Metastatic Phenotype of Pancreatic Cancer Cells by Enhancing Their Migratory Capacity Through the Control of Oxidative Phosphorylation [Poster presentation]. Belgian Society for Cell and Developmental Biology - Spring Meeting, Liège, Belgium.

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Di Valentin, E., Goval, J.-J., Bellahcene, A., Castronovo, V., & Peulen, O. (June 2019). Myoferlin contributes to the metastatic phenotype of pancreatic cancer cells by enhancing their migratory capacity through the control of oxidative phosphorylation. Cancers, 11 (6). doi:10.3390/cancers11060853

Costanza, B., Rademaker, G., Tiamiou, A., De Tullio, P., Leenders, J., Blomme, A., Bellier, J., Bianchi, E., Turtoi, A., Delvenne, P., Bellahcene, A., Peulen, O.* , & Castronovo, V.*. (2019). TGFBI, an ECM interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration. International Journal of Cancer. doi:10.1002/ijc.32247

Nokin, M.-J., Bellier, J., Durieux, F., Peulen, O., Rademaker, G., Gabriel, M., Monseur, C., CHARLOTEAUX, B., Verbeke, L., van Laere, S., RONCARATI, P., Herfs, M., Lambert, C., Scheijen, J., Schalkwijk, C., Colige, A., Caers, J., Delvenne, P., Turtoi, A., ... Bellahcene, A. (2019). Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer. Breast Cancer Research, 21(1, 11. doi:10.1186/s13058-018-1095-7

Rademaker, G., Costanza, B., Bellier, J., Herfs, M., Peiffer, R., Agirman, F., Maloujahmoum, N., Habraken, Y., Delvenne, P., Bellahcene, A., Castronovo, V.* , & Peulen, O.*. (2019). Human colon cancer cells highly express myoferlin to maintain a fit mitochondrial network and escape p53-driven apoptosis. Oncogenesis. doi:10.1038/s41389-019-0130-6

Brohée, L., Peulen, O., Nusgens, B., Castronovo, V., Thiry, M., Colige, A., & Deroanne, C. (04 May 2018). Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression. Scientific Reports, 8 (1), 7050. doi:10.1038/s41598-018-25340-9

Rademaker, G., Hennequière, V., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (April 2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene, 37 ((32)), 4398-4412. doi:10.1038/s41388-018-0287-z

Costanza, B., Turtoi, A., Bellahcene, A., Hirano, T., Peulen, O., Blomme, A., Hennequiere, J., MUTIJIMA NZARAMBA, E., Boniver, J., Meuwis, M.-A., JOSSE, C., KOOPMANSCH, B., SEGERS, K., Yokobori, T., Fahmy, K., Thiry, M., COIMBRA MARQUES, C., Garbacki, N., Colige, A., ... Castronovo, V. (2018). Innovative methodology for the identification of soluble biomarkers in fresh tissues. Oncotarget, 9 (12), 10665-10680. doi:10.18632/oncotarget.24366

Amorim, C., Andris, F., Arckens, L., Arnould, T., Aron, S., Bakker, J., Balligand, M., Balthazart, J., Baron, F., Beck, B., Beguin, Y., Behets, C., Bellefroid, E., Bertrand, L., Bettendorff, L., Bindels, L., Blankert, B., Blanpain, C., Bondue, A., ... Wittamer, V. (2017). L’expérimentation animale reste indispensable (OPINION). La Libre Belgique.

Chiavarina, B., Nokin, M.-J., Bellier, J., Durieux, F., BLETARD, N., Sherer, F., LOVINFOSSE, P., Peulen, O., Verset, L., Dehon, R., Demetter, P., Turtoi, A., Uchida, K., Goldman, S., Hustinx, R., Delvenne, P., Castronovo, V., & Bellahcene, A. (2017). Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer. International Journal of Molecular Sciences, 18 (1). doi:10.3390/ijms18010213

Nokin, M.-J., Durieux, F., Bellier, J., Peulen, O., Uchida, K., Spiegel, D. A., Cochrane, J. R., Hutton, C. A., Castronovo, V., & Bellahcene, A. (2017). Hormetic potential of methylglyoxal, a side-product of glycolysis, in switching tumours from growth to death. Scientific Reports, 7 (1), 11722. doi:10.1038/s41598-017-12119-7

Blomme, A., Fahmy, K., Peulen, O., Costanza, B., Fontaine, M., Struman, I., Baiwir, D., De Pauw, E., Thiry, M., Bellahcene, A., Castronovo, V.* , & Turtoi, A.*. (2016). Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes. Oncotarget. doi:10.18632/oncotarget.13276

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Scheijen, J., Schalkwijk, C., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., ... Bellahcene, A. (2016). Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP- mediated tumor growth and metastasis. eLife. doi:10.7554/eLife.19375

Henry, A., Nokin, M.-J., Leroi, N., Lallemand, F., Lambert, J., Goffart, N., RONCARATI, P., BIANCHI, E., Peixoto, P., Blomme, A., Turtoi, A., Peulen, O., Habraken, Y., Scholtes, F., Martinive, P., Delvenne, P., Rogister, B., Castronovo, V., & Bellahcene, A. (2016). New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity. Oncotarget. doi:10.18632/oncotarget.11483

Blomme, A., Cusumano, P., Peulen, O., Bellahcene, A., Castronovo, V., & Turtoi, A. (2016). L'asporine : une nouvelle defense naturelle contre le cancer du sein. MS. Medecine Sciences, 32 (11), 1019-1022. doi:10.1051/medsci/20163211020

Costanza, B., Blomme, A., Bellahcene, A., Peulen, O., MUTIJIMA NZARAMBA, E., DELVENNE, P., De Pauw, E., DETRY, O., COIMBRA MARQUES, C., Castronovo, V., & Turtoi, A. (2016). EXPEL: A Novel Non-Destructive Method for Mining Soluble Tumor Biomarkers. Acta Gastro-Enterologica Belgica, 79 (1), 11.

Fahmy, K., Peulen, O., Castronovo, V., Bellahcene, A., Turtoi, A., Thiry, M., Delvenne, P., PEIXOTO, P., Gonzalez, A., & ARAFA, M. (31 January 2015). Myoferlin: an indispensable component in VEGFA secretion by pancreas cancer cells [Poster presentation]. ASSOCIATION BELGE POUR L'ETUDE DU CANCER, Bruxelles, Belgium.

Fahmy, K., Gonzalez, A., Arafad, M., Turtoi, A., Bellahcene, A., DELVENNE, P., Thiry, M., Castronovo, V., & Peulen, O. (27 January 2015). Myoferlin: an indispensable component in VEGR-A secretion by pancreatic cancer cell [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium.

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Smargiasso, N., Baiwir, D., De Pauw, E., De Tullio, P., Thiry, M., Peulen, O., Turtoi, A., Castronovo, V., & Bellahcene, A. (27 January 2015). Accumulation of methylglyoxal, a glycolysis by-product modulates YAP1 transcription co-factor localization and activity in human breast cancer cells through HSP90 modification [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium.

Castronovo, C., Castronovo, V., Nikkels, A., & Peulen, O. (2015). LES ACTIVITES ANTI-CANCEREUSES DE LA VITAMINE D: les observations, les doutes et les certitudes. Revue Médicale de Liège, 70 (10), 495-500.

Costanza, B., Blomme, A., Bellahcene, A., MUTIJIMA NZARAMBA, E., Peulen, O., & DELVENNE, P. (January 2015). EXPEL: A Novel Non-Destructive Method for Mining Soluble Tumor Biomarkers [Poster presentation]. Belgian Association Cancer Research.

Frère, A., Tempelaar, S., Peixoto, P., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (28 August 2014). Polyplex based on polycarbonate polymesr for an efficient delivery of an anti-angiogenic siRNA [Paper presentation]. Translational Nanomedicine, Angers, France.

Chiavarina, B.* , Nokin, M.-J.* , Durieux, F., BIANCHI, E., Turtoi, A., Peulen, O., Peixoto, P., Irigaray, P., Uchida, K., Belpomme, D., Delvenne, P., Castronovo, V., & Bellahcene, A. (2014). Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes. Oncotarget. doi:10.18632/oncotarget.2121

Frère, A., Kawalec, M., Tempelaar, S., Peixoto, P., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (2014). Polyplex Based On Polycarbonate Polymers For An Efficient Delivery Of An Anti-Angiogenic siRNA [Poster presentation]. 3rd NanoFar Autumn School, Brussels, Belgium.

Suarez-Carmona, M., Hubert, P., Gonzalez, A., Duray, A., RONCARATI, P., Erpicum, C., Boniver, J., Castronovo, V., Noël, A., Saussez, S., Peulen, O., Delvenne, P., & Herfs, M. (2014). DeltaNp63 isoform-mediated beta-defensin family up-regulation is associated with (lymph)angiogenesis and poor prognosis in patients with squamous cell carcinoma. Oncotarget, 5 (7), 1856-1868. doi:10.18632/oncotarget.1819

Peulen, O.* , Gonzalez, A.* , Peixoto, P., Turtoi, A., Mottet, D., Delvenne, P., & Castronovo, V. (11 September 2013). The Anti-Tumor Effect of HDAC Inhibition in a Human Pancreas Cancer Model Is Significantly Improved by the Simultaneous Inhibition of Cyclooxygenase 2. PLoS ONE, 8 (9), 75102. doi:10.1371/journal.pone.0075102

Dumont, B., Castronovo, V., Peulen, O., BLETARD, N., Clézardin, P., Delvenne, P., De Pauw, E., Turtoi, A., & Bellahcene, A. (2012). Differential proteomic analysis of a human breast tumor and its matched bone metastasis identifies cell membrane and extracellular proteins associated with bone metastasis. Journal of Proteome Research. doi:10.1021/pr201022n

Bénéré, E., Van Assche, T., Van Ginneken, C., Peulen, O., Cos, P., & Maes, L. (2012). Intestinal Growth and Pathology og Giardia duodenalis assemblage subtype AI, AII, B end E in the gerbil model. Parasitology, 139, 424-433.

NIZET, J.-L., Gonzalez, A., Peulen, O., & Castronovo, V. (2011). Transferts graisseux au niveau du sein: implications oncologiques. Revue Médicale de Liège, 66 (5-6), 362-6.

LORQUET, S., Berndt, S., Blacher, S., Gengoux, E., Peulen, O., Maquoi, E., Noël, A., Foidart, J.-M., Munaut, C., & Pequeux, C. (2010). Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment. FASEB Journal, 24 (10), 3782-95. doi:10.1096/fj.09-149070

Bruyere, F., Melen-Lamalle, L., Berndt, S., Peulen, O., Foidart, J.-M., & Noël, A. (2008). The lymphatic ring assay: a 3D-culture model of lymphangiogenesis. Nature Protocols. doi:10.1038/nprot.2008.86

Nollevaux, G., Deville, C., Elmoualij, B., Zorzi, W., Deloyer, P., Schneider, Y.-J., Peulen, O., & Dandrifosse, G. (02 May 2006). Development of a serum-free co-culture of human intestinal epithelium cell-lines (Caco-2/HT29-5M21). BMC Cell Biology, 7, 20. doi:10.1186/1471-2121-7-20

Rusu, D., Loret, S., Peulen, O., Mainil, J., & Dandrifosse, G. (01 December 2005). Immunochemical, biomolecular and biochemical characterization of bovine epithelial intestinal primocultures. BMC Cell Biology, 6, 42-53. doi:10.1186/1471-2121-6-42

Pluske, J. R., Kerton, D. J., Cranwell, P. D., Campbell, R. G., Mullan, B. P., King, R. H., Power, G. N., Pierzynowski, S. G., Westrom, B., Rippe, C., Peulen, O., & Dunshea, F. R. (2003). Age, sex, and weight at weaning influence organ weight and gastrointestinal development of weanling pigs. Australian Journal of Agricultural Research, 54 (5), 515-527. doi:10.1071/AR02156

Dandrifosse, G., Peulen, O., El Khefif, N., Deloyer, P., Dandrifosse, A.-C., & Grandfils, C. (February 2000). Are Milk Polyamines Preventive Agents against Food Allergy? Proceedings of the Nutrition Society, 59 (1), 81-6. doi:10.1017/S0029665100000100